01 1Azico Biophore India Private Limited
02 1Chongqing Huapont Pharmaceutical Co., Ltd
03 1Micro Labs Limited
04 1Sterling Pharma Solutions Limited
01 4Acrivastine
01 1China
02 2India
03 1United Kingdom
NDC Package Code : 69575-4006
Start Marketing Date : 2015-11-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48943-0035
Start Marketing Date : 2023-08-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42571-512
Start Marketing Date : 2024-03-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50384-0300
Start Marketing Date : 1994-03-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Acrivastine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Acrivastine, including repackagers and relabelers. The FDA regulates Acrivastine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Acrivastine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Acrivastine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Acrivastine supplier is an individual or a company that provides Acrivastine active pharmaceutical ingredient (API) or Acrivastine finished formulations upon request. The Acrivastine suppliers may include Acrivastine API manufacturers, exporters, distributors and traders.
click here to find a list of Acrivastine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Acrivastine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Acrivastine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Acrivastine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Acrivastine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Acrivastine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Acrivastine suppliers with NDC on PharmaCompass.
We have 4 companies offering Acrivastine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
